The Effect Of Saffron ( Crocus Sativus L.) Supplementation On Blood Pressure, And Renal And Liver Function In Patients With Type 2 Diabetes Mellitus: A Double-blinded, Randomized Clinical Trial
Notes for this study:
||SBP. Placebo: before 127.4±15.3, after 128.3±12.4. Saffron: before 132.7±21.3, after 124.5±13.2. DBP Placebo: before 79.7±11.1, after 75.9±14. Saffron: before 79.5±10.8, after 76.7±9.9.
|Number of Subjects
||30-44, 45-64, 65+
In a randomized, double-blind, placebo-controlled trial, 80 participants with type 2 diabetes took 100 mg of saffron powder or placebo for 12 weeks.
There wasn't an effect on liver enzymes, creatinine, urea, or albumin. There was a reduction in systolic blood pressure but not diastolic.
The trial was preregistered: IRCT201510259472N9